SIRT5 and hypertrophic cardiomyopathy: However, we did not observe any defective hypertrophic cardiomyopathy in Sirt5 KO mice at 15 weeks of age, which was also not observed in Sirt5 KO mice at 12–21 weeks of age in Hershberger’s work [61].